NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

眼科公司合同趨勢調查:併購,融資,業務/技術銷售(2020年)

2020 Ophthalmic Deals Book: Mergers and Acquisitions, Financing, and Business/Technology Sales

出版商 Market Scope, LLC 商品編碼 987745
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
眼科公司合同趨勢調查:併購,融資,業務/技術銷售(2020年) 2020 Ophthalmic Deals Book: Mergers and Acquisitions, Financing, and Business/Technology Sales
出版日期: 2021年01月31日內容資訊: 英文
簡介

本報告涵蓋了眼科公司在2019年和2020年的資本交易,包括風險資本,私募股權,公開募股投資和公司出售。該研究報告具有許多新功能,例如對眼科相關市場的每個部門進行詳細分析,包括每個部門的交易數量和交易總數,與其他部門相比的分配,按應用和類型劃分我們還會分析資金籌集情況,即每個部門籌集資金最多的公司。

本報告分析了眼科領域的投資,並提供了評估各種技術市場價值的信息,並得到了與眼科相關的新企業的投資額和數量的支持。該報告包含有關此期間進行的投資的信息,包括風險投資,公開募股,許可,目標成就獎勵,產品和公司的銷售以及重大借款。

主要內容

  • 按資金用途對資本交易進行分類:新企業,商業股權,公司出售,支付許可費
  • 四種投資類型的分析:戰略投資者,風險投資,公開募股,私募股權
  • 詳細分析與眼科相關的七個領域的交易:乾眼症,視網膜,青光眼,白內障,診斷,角膜,屈光功能以及與每個領域的主要投資者的往來
  • 資本交易的關鍵指標:公司募集資金,投資和籌集最多資金的指標
  • 本研究報告中提及的公司:2019年或2020年,由300多家公司籌集的資金總額和30家公司的概況籌集了超過9,900萬美元的資金

2020年眼科交易的細分:按部門

注意:盒子的大小是部門(2020)年。

公司列表不完整

>
目錄

What's New:

Market Scope's new "2020 Ophthalmic Deals Book" covers 175 ophthalmic company transactions in 2019 and 2020 by over 150 investors, including investments by venture capital firms, private equity, public stock offerings, and sales of companies. The 2020 deals book details fundraising activities and categorizes transactions in ophthalmology by pharmaceuticals/biopharmaceutics and medical devices/equipment. New in 2020, the deals book provides a quarterly view by sector for the past 12 quarters.

The "2020 Ophthalmic Deals Book" analyzes investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

The report covers investments in ophthalmic ventures in 2020, with comparisons to 2018 and 2019, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market-and companies looking to raise funds.

  • Transactions categorized by fund use: new venture, commercial equity, sale of companies, and license payments.
  • Four investment types analyzed in this report: strategic investors, venture capital, public offerings, and private equity.
  • Detailed transaction analysis provided for seven ophthalmic sectors: dry eye, retina, glaucoma, cataract, diagnostic, cornea, and refractive. Key investors and transactions in each sector are included.
  • Key metrics in this report include: companies raising funds, companies making investments, and top funded companies.
  • Company coverage: Over 300 companies, along with total funds earned, are included in the report; company profiles are provided for 30 companies that raised more than $99 million in 2019 or 2020.

Breakdown of 2020 Ophthalmic Transactions by Sector

          Note: Box size indicates sector total transaction amount 2020.

          Company list is not comprehensive.

This report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market. The information covers investments in ophthalmic ventures during 2020, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. Ophthalmic ventures during 2018 and 2019 are also referenced for historical context.